
Padmavathi Baskar
Examiner (ID: 13817, Phone: (571)272-0853 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1641, 1645 |
| Total Applications | 1590 |
| Issued Applications | 1047 |
| Pending Applications | 159 |
| Abandoned Applications | 391 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15267441
[patent_doc_number] => 20190382454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => A MODIFIED PEPTIDE AS AN ANTICANCER AGENT
[patent_app_type] => utility
[patent_app_number] => 15/555819
[patent_app_country] => US
[patent_app_date] => 2016-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555819
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555819 | A MODIFIED PEPTIDE AS AN ANTICANCER AGENT | Mar 6, 2016 | Abandoned |
Array
(
[id] => 10997418
[patent_doc_number] => 20160194363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'Compositions and Methods Related to Protein A (SpA) Variants'
[patent_app_type] => utility
[patent_app_number] => 15/060861
[patent_app_country] => US
[patent_app_date] => 2016-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 46686
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15060861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/060861 | Compositions and Methods Related to Protein A (SpA) Variants | Mar 3, 2016 | Abandoned |
Array
(
[id] => 10820509
[patent_doc_number] => 20160166673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'STAPHYLOCOCCUS AUREUS PROTEINS AND NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 15/050107
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20796
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050107 | Staphylococcus aureus proteins and nucleic acids | Feb 21, 2016 | Issued |
Array
(
[id] => 11595765
[patent_doc_number] => 09642909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants'
[patent_app_type] => utility
[patent_app_number] => 15/046575
[patent_app_country] => US
[patent_app_date] => 2016-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 6650
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15046575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/046575 | Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants | Feb 17, 2016 | Issued |
Array
(
[id] => 10812185
[patent_doc_number] => 20160158345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/042189
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17090
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15042189
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/042189 | Process for preparing pneumococcal polysaccharide-protein conjugates | Feb 11, 2016 | Issued |
Array
(
[id] => 13234959
[patent_doc_number] => 10130663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Bacteria over-expressing c-di-AMP and therapeutic methods
[patent_app_type] => utility
[patent_app_number] => 15/550434
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 70
[patent_no_of_words] => 8618
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550434
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550434 | Bacteria over-expressing c-di-AMP and therapeutic methods | Feb 9, 2016 | Issued |
Array
(
[id] => 11031521
[patent_doc_number] => 20160228477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'METHOD FOR IMPROVING SKIN CONDITION OR ANTI-MICROORGANISMS OR ANTI-OXIDATION USING LACTOBACILLUS SAKEI MD HONEYSUCKLE'
[patent_app_type] => utility
[patent_app_number] => 15/018779
[patent_app_country] => US
[patent_app_date] => 2016-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 6445
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15018779
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/018779 | Method for improving skin condition or anti-microorganisms or anti-oxidation using | Feb 7, 2016 | Issued |
Array
(
[id] => 10648304
[patent_doc_number] => 09364528
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-06-14
[patent_title] => 'Combination neisserial compositions'
[patent_app_type] => utility
[patent_app_number] => 15/015041
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 56
[patent_no_of_words] => 58959
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015041
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015041 | Combination neisserial compositions | Feb 2, 2016 | Issued |
Array
(
[id] => 11535954
[patent_doc_number] => 09610342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-04
[patent_title] => 'Combination neisserial compositions'
[patent_app_type] => utility
[patent_app_number] => 15/015004
[patent_app_country] => US
[patent_app_date] => 2016-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 56
[patent_no_of_words] => 58904
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015004
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015004 | Combination neisserial compositions | Feb 2, 2016 | Issued |
Array
(
[id] => 12151529
[patent_doc_number] => 20180022794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'ANTI-RHO GTPASE CONFORMATIONAL SINGLE DOMAIN ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/548578
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16151
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548578 | Anti-Rho GTPase conformational single domain antibodies and uses thereof | Feb 1, 2016 | Issued |
Array
(
[id] => 12343668
[patent_doc_number] => 09950053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => Use of the
[patent_app_type] => utility
[patent_app_number] => 15/013454
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 21
[patent_no_of_words] => 26704
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15013454
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/013454 | Use of the | Feb 1, 2016 | Issued |
Array
(
[id] => 10797855
[patent_doc_number] => 20160144012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'LIVE-ATTENUATED COMPOSITIONS FOR BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/012211
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10501
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012211
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012211 | LIVE-ATTENUATED COMPOSITIONS FOR BACTERIAL INFECTIONS | Jan 31, 2016 | Abandoned |
Array
(
[id] => 14130135
[patent_doc_number] => 20190099457
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => Immunomodulatory Composition Comprising Bifidobacteria
[patent_app_type] => utility
[patent_app_number] => 15/544989
[patent_app_country] => US
[patent_app_date] => 2016-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544989
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/544989 | Immunomodulatory composition comprising bifidobacteria | Jan 26, 2016 | Issued |
Array
(
[id] => 12449124
[patent_doc_number] => 09982228
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Modified gram positive bacteria and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/003426
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22508
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15003426
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/003426 | Modified gram positive bacteria and uses thereof | Jan 20, 2016 | Issued |
Array
(
[id] => 13824023
[patent_doc_number] => 20190015496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => Proteins and nucleic acids useful in vaccines targeting Klebsiella Pneumoniae
[patent_app_type] => utility
[patent_app_number] => 15/542580
[patent_app_country] => US
[patent_app_date] => 2016-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43952
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542580
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542580 | Proteins and nucleic acids useful in vaccines targeting | Jan 11, 2016 | Issued |
Array
(
[id] => 13397693
[patent_doc_number] => 20180250389
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-09-06
[patent_title] => VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 14/987770
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987770 | Vaccine comprising | Jan 4, 2016 | Issued |
Array
(
[id] => 13397693
[patent_doc_number] => 20180250389
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2018-09-06
[patent_title] => VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 14/987770
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987770
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987770 | Vaccine comprising | Jan 4, 2016 | Issued |
Array
(
[id] => 11122004
[patent_doc_number] => 20160318979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'INTERACTION OF MORAXELLA CATARRHALIS WITH EPITHELIAL CELLS, EXTRACELLULAR MATRIX PROTEINS AND THE COMPLEMENT SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/986104
[patent_app_country] => US
[patent_app_date] => 2015-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 23102
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14986104
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/986104 | Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system | Dec 30, 2015 | Issued |
Array
(
[id] => 10763294
[patent_doc_number] => 20160109449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'ANTIBODIES OR FRAGMENTS THEREOF DIRECTED AGAINST A STAPHYLOCOCCUS AUREUS EPITOPE OF ISAA OR ISAB'
[patent_app_type] => utility
[patent_app_number] => 14/984958
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5433
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14984958
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/984958 | Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB | Dec 29, 2015 | Issued |
Array
(
[id] => 10978498
[patent_doc_number] => 20160175441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SPA) ANTIBODIES AS AN ENHANCER OF IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/968023
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 77347
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14968023
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/968023 | Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response | Dec 13, 2015 | Issued |